Cleared Special

Insulin Syringes (K242434) - FDA 510(k) Clearance

Class II General Hospital device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K242434 · Chirana T. Injecta · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2024
Decision
130d
Days
Class 2
Risk

K242434 is an FDA 510(k) clearance for the Insulin Syringes. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Chirana T. Injecta (Stará Turá, SK). The FDA issued a Cleared decision on December 24, 2024 after a review of 130 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Chirana T. Injecta devices

Submission Details

510(k) Number K242434 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 16, 2024
Decision Date December 24, 2024
Days to Decision 130 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1d slower than avg
Panel avg: 129d · This submission: 130d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Empirical Technologies
Nathan Wright

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FMF Syringe, Piston

All 239
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K242434.
GPS Advanced
K251648 · Prosidyan, Inc. · Jun 2025
GO-PEN®
K250262 · Go-Pen Aps · Apr 2025
GraftGun Universal Graft Delivery System (GDS)
K243580 · SurGenTec, LLC · Feb 2025
Sofjec (Single use Needle)
K241856 · Hlb Lifescience Co., Ltd. · Dec 2024
Sol-M™ Slip Tip Syringe without Needle, Sol-M™ Eccentric Tip Syringe without Needle
K242099 · Sol-Millennium Medical, Inc. · Oct 2024
Luer Lock Syringe with Safety Needle
K241821 · Sol-Millennium Medical, Inc. · Sep 2024